Wednesday, December 06, 2006
Novartis Highlights Strong R&D Pipeline, Plans For Multiple New ...
Medical News Today (press release), UK - Nov 29, 2006... Projects that have been terminated include XBD173 (generalized anxiety disorder) and AAE581 ... cost generics, human vaccines and leading self-medication OTC brands ...
Source: www.medicalnewstoday.com
Click here for more information about remedies for anxiety and depression
